These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8916979)

  • 1. The effects of oestrogen deficiency on the skeleton and its prevention.
    Fogelman I
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():5-9. PubMed ID: 8916979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis prevention with sex hormone replacement therapy.
    Rozenberg S; Vandromme J; Kroll M; Pastijn A; Degueldre M
    Int J Fertil Menopausal Stud; 1994; 39(5):262-71. PubMed ID: 7820159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens in prevention and treatment of osteoporosis.
    Lindsay R
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1806-10. PubMed ID: 2532784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
    Kanis JA
    Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal osteoporosis treatment guidelines.
    Sambrook P; O'Neill S; Diamond T; Flicker L; MacLennan A
    Aust Fam Physician; 2000 Aug; 29(8):751-3, 756-8. PubMed ID: 10958021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].
    Burckhardt P
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1926-30. PubMed ID: 10635085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the preventive role of estro-progestogens and non-hormonal therapies in postmenopausal osteoporosis].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):677-83. PubMed ID: 8991900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sex hormones and osteoporosis: a physiological perspective for prevention and therapy].
    da Silva JA; Porto A
    Acta Med Port; 1997 Oct; 10(10):689-95. PubMed ID: 9477594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60.
    Studd J
    Climacteric; 2009 Jun; 12(3):206-9. PubMed ID: 19437196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoporosis treatment by gynecologist].
    Mizunuma H
    Nihon Rinsho; 2003 Feb; 61(2):268-73. PubMed ID: 12638220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate].
    Buffo L; Rossini M; Buoncristiano A; Girardello S; Zamberlan N; Diani F; Adami S
    Minerva Ginecol; 1996 Jun; 48(6):263-72. PubMed ID: 8927288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
    Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
    Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.
    North American Menopause Society.
    Menopause; 2002; 9(2):84-101. PubMed ID: 11875327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
    Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral osteoporosis: a review and its dental implications].
    Inagaki K; Kurosu Y; Sakano M; Yamamoto G; Kikuchi T; Noguchi T; Yano H; Izawa H; Hachiya Y
    Clin Calcium; 2007 Feb; 17(2):157-63. PubMed ID: 17272871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diphosphonates--pharmacology and clinical use].
    Aaseth J; Syversen U; Førre O
    Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1064-6. PubMed ID: 9531831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.